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200 Abstractsand biology of transplanted stem cells in the living subject. Recent advances
in molecular biology and imaging have allowed the successful non-invasive
monitoring of transplanted stem cells in the living subject. The ideal imaging
method should provide the information of (1) Real-time visualization of stem
cell delivery; and (2) Determination of location(s) and Quantification of cells
over time. The chosen labeling modality should not interact with the normal
functions of the stem cell and provides a good contrast between background
and the target signal under study, achieving a large signal-to-noise ratio.
Reporter gene-bioluminescence imaging (BLI) is based on light emission and
detection by specific cooled charge coupled device (CCD) cameras. Similar
to other reporter gene strategies, the BLI signal is only emitted when cells
are viable, and thus can be used for the longitudinal monitoring of stem cell
survival and study of cell status. BLI has been successfully used for in vivo
study of cell delivery and monitoring of stem cell viability, fate, interaction
between stem cells and microenvironments in small living animals.
We have investigated the distribution of systemically delivered luciferase
labeled MSCs in fracture animal model and tumor bearing animals. The
whereabouts of the labelled stem cells are monitored using the in vivo im-
aging system (IVIS 200, Exogen, USA), and accessed the efficiency of using
stem cells therapy for promoting fracture repair (Fig. 1) and anti-cancer
gene therapy.
Fig. 1. Allogenic Luc-MSCs were injected into the fracture site in mice, and
were monitored using in vivo imaging system. Allogenic MSCs became
undectable 14 days after injection. All animals did not show obvious adverse
side effects.
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Optical imaging techniques are among the most powerful techniques in
preclinical research, specifically for the imaging of rodents. It includes (i)
methods suited for mesoscopic (spatial resolution of about 1 mm) whole
body non-invasive imaging, specifically fluorescent and bioluminescent
imaging, (ii) microscopic techniques, most notably multiphoton and confocal
microscopy, and (iii) spectroscopic approaches such as Raman and Fourier
Transform Infrared imaging and mass spectroscopy imaging.A key reason for the attractiveness of optical imaging is the possibility to
exploit the extremely powerful methods of genetic engineering. For
example, transgenic mouse models can be generated that feature near
infrared reporter signals associated with specific gene expression. By this
mechanism of molecular imaging, morphologic imaging can be extended to
in vivo functional imaging.
Optical imaging of bone is feasible but presents specific hurdles that to date
have only partially been overcome. Light is strongly scattered and absorbed
leading to strong attenuation and resulting limits in spatial resolution,
decreasing rapidly with increasing depth. This also leads to bias in the
quantitative evaluation of optical signals. On the positive side, due to the
strong bone binding properties of bisphosphonates, bone labeling molecules
have been developed. These bind to mineral on bone surface and permit in
vivo insight into bone turnover. In this way, they work similar to serum
markers of bone turnover, but they provide this information in a spatially
resolved way, including 3-D depiction using fluorescent molecular tomogra-
phy (FMT).
Ex vivo optical imaging provides powerful assessment tools specifically for
the organic components of bone tissue. Second harmonic generation (SHG) is
a contrast mechanism of multiphoton microscopy specific to collagen.
Mineral to matrix ratios and subtype analysis of collagen is feasible with
the aforementioned spectroscopic imaging approaches, promising to help
elucidating bone fragility in secondary osteoporosis and other disorders, e.g.
effects of diabetes on bone.
The goals for research in the coming years include the refinement of these
methods, the linking of mesoscopic with microscopy techniques in order to
obtain a comprehensive assessment of as many dimensions of bone quality as
possible, the in vivo assessment of bone function down to the cellular level,
in order to improve the assessment of bone metabolism and other skeletal
disorders.
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Abstracts 201Musculoskeletal imaging techniques, especially those non-destructive ones,
such as clinical or laboratory CT, MRI, and ultrasound are able to provide not
only 2-D and 3-D reconstructed images of the related organs or tissues, but
also quantifications of the relevant parameters. The advance bioimaging
technologies developed for the above applications are also extended by
incorporating imaging contrast-enhancement materials. All the data-set
enable us to design 3D tissue or organ structures of our musculoskeletal
system using rapid 3D prototyping technologies. Above imaging technologies
and application protocols also provide an excellent evaluation tools
qualitatively and quantitatively for assessment of the implanted 3-D rapid-
prototyped scaffolds preclinically and clinically. Multidisciplinary collabora-
tions with biomedical engineers, biomaterial engineers, basic and clinical
scientists are essential.
The author’s group has been using a unique low temperature 3D rapid-
prototyping technology to design and produce bioactive and degradable
bone scaffold composite materials. Innovative bioactive materials are from
nature herbs, biological factors, and cost-effective biometallic elements.
Clinical indication-orientated animal models have been established for
preclinical evaluations. Efforts are made for optimization of the implantable
products to ensure maximal biocompatibility and osteoconductivity with
sufficient mechanical properties.
Additional efforts are also be made towards translational medicine, here
refer to product registration and multi-center clinical trials for innovative
rapid-prototyped 3D skeletal scaffolds before becoming commercial avail-
able products for our routine clinical applications.
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Osteoporotic fractures are associated with considerable morbidity and
mortality, and the use of 3D high resolution imaging has offered new
opportunities to learn about bone quality that may help in the development
of novel treatments and diagnostic techniques aimed at improving bonehealth. The advent of high-resolution peripheral quantitative computed
tomography scanners (HR-pQCT, XtremeCT, Scanco Medical) a decade ago
opened new opportunities to investigate natural changes in bone quality
with aging, the effects of treatments on the underlying bone micro-
architecture, and the ability to apply techniques such as the finite element
analysis to non-invasively assess bone strength. In the past year, a new
version of HR-pQCT has become available (XtremeCTII) which further
advances the potential to assess bone quality.
In this work we present our population-based cohort that has been a major
focus of our laboratory over the past decade. We have previously established
the age-related changes in bone microarchitecture based on a cross-
sectional study design recently, and here we begin to explore the longitu-
dinal analysis of that same population, and use that information to under-
stand the true individual age-related changes in bone architecture. With the
newfound ability to measure at a 61 mm voxel size (Fig. 1), we explore the
challenges of having a continuity of research studies that will span two
generations of these systems. Specially, we will address the major issues
that need to be resolved so that the wealth of longitudinal data collected by
all users of HR-pQCT can be effectively continued. Also, we explore the
ability to apply advanced analysis methods to the new technology, including
both the finite element method and direct measures of bone microarchi-
tecture. Finally, we will demonstrate the potential to being studying bone
quality for other research applications, such as the periarticular bone
quality at the knee and elbow, which is important for learning about
diseases such as osteoarthritis and with implications for total joint
replacement. In summary, the introduction of new HR-pQCT technology
offers exciting new opportunities for the study of bone quality.
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